In collaboration with investigators from the Women’s Health Initiative, investigators in DCEG are conducting a nested case-control study of endometrial and ovarian cancers to assess the roles of estrogens, estrogen metabolites, and androgens in the etiologies of these cancers. Cases and shared controls have been drawn from the Women’s Health Initiative Observational Study (WHIOS) cohort. This effort benefits from unique WHIOS resources, including large numbers of cancer cases, prospectively collected serum and baseline data on important cancer risk factors. Assays will relate circulating estrogens and metabolites as measured by LC/MS2 to cancer risk based on approximately 240 ovarian and 430 endometrial cancer cases.
For more information, contact Nicolas Wentzensen.